Somnair is introducing the first clinically effective, non-invasive neurostimulation solution for obstructive sleep apnea. The device is an oral appliance which delivers stimulation to novel and patent-pending neuroanatomical targets in the palate and pharynx to prevent airway collapse that ensues from a lack of neuromuscular tone during sleep.
